muscle loss on glp-1 Study finds receptor agonists target fat over for weight GLP-1 & Muscle Loss: Evidence

In the LEADER trial, Liraglutide demonstrated substantial cardiovascular and renal benefits in patients with Type 2 DM and CKD, while maintaining a favorable safety profile [91]

Tirzepatide is injected subcutaneously on a weekly basis

Expert Opinions Endocrinologists Take Dr

Liu L, Liu J, Wong WT, Tian XY, Lau CW, Wang YX, Xu G, Pu Y, Zhu Z, Xu A, et al: Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism

10.1093/eurjhf/hfr146

I knew that Saba GLP-1 was available in January of 2025 so I wanted to wait and use the natural product to see how it compares